Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Aug 28, 2026

ORIC — ORIC Pharmaceuticals, Inc. Dilution Risk Tracker

Track ORIC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ORIC — Get alerts when the score changes →

As of August 28, 2026, ORIC Pharmaceuticals, Inc. (ORIC) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. ORIC Pharmaceuticals, Inc. has a market capitalization of $874.72M, 103.65M shares outstanding, 183 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $60.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
31
💰 Cash Runway
40
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $60M remaining capacity
🔔 Track ORIC — Get forecast alerts →

Market Data

Market Cap$874.72M
Shares Outstanding103.65M
Float82.53M
Cash$128.47M
Debt$10.50M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 7.2% shares (2026Q1 vs prior)
183 institutional holders · 130.98M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 7.37M shares
#2 Nextech Invest, Ltd. 7.16M shares
#3 EcoR1 Capital, LLC 6.73M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest21.80M
Days to Cover13.6
% of Float26.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-05-31
xbrl XBRL CONVERTIBLE 2020-12-31
4 INSIDER TRANSACTION 2026-02-26
8-K 8K EVENT 2026-02-23
424B5 ATM 2026-02-23
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ORIC Dilution Snapshot

ORIC Pharmaceuticals, Inc. (ORIC) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ORIC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ORIC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ORIC
ORIC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.